{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T22:49:51Z","timestamp":1791326991606,"version":"4.3.1"},"reference-count":4,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure: European Journal of Epilepsy"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.seizure.2026.08.016","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T23:29:23Z","timestamp":1787095763000},"page":"118-120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Remarkable seizure reduction with trofinetide treatment in an adult with Rett syndrome: A case report"],"prefix":"10.1016","volume":"142","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-1260-5564","authenticated-orcid":false,"given":"Semihan","family":"Adegbite","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0064-8136","authenticated-orcid":false,"given":"Pooneh Memar","family":"Ardestani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7197-3094","authenticated-orcid":false,"given":"Maromi","family":"Nei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.seizure.2026.08.016_bib0001","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.pediatrneurol.2012.11.001","article-title":"Rett syndrome and epilepsy: an update for child neurologists","volume":"48","author":"Dolce","year":"2013","journal-title":"Pediatr Neurol"},{"issue":"10","key":"10.1016\/j.seizure.2026.08.016_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.medj.2024.06.007","article-title":"Trofinetide for the treatment of Rett syndrome: long-term safety and efficacy results of the 32-month, open-label LILAC-2 study","volume":"5","author":"Percy","year":"2024","journal-title":"Med"},{"issue":"1","key":"10.1016\/j.seizure.2026.08.016_bib0003","doi-asserted-by":"crossref","DOI":"10.1080\/23995270.2024.2375191","article-title":"Improvement in symptoms of Rett syndrome with trofinetide beyond clinical trial efficacy assessments: case reports","volume":"4","author":"Ryther","year":"2024","journal-title":"Future Rare Dis"},{"issue":"10","key":"10.1016\/j.seizure.2026.08.016_bib0004","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.tips.2023.06.008","article-title":"Trofinetide: a pioneering treatment for Rett syndrome","volume":"44","author":"Parent","year":"2023","journal-title":"Trends Pharmacol Sci"}],"container-title":["Seizure: European Journal of Epilepsy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131126002438?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131126002438?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:50:47Z","timestamp":1791323447000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131126002438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":4,"alternative-id":["S1059131126002438"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2026.08.016","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Remarkable seizure reduction with trofinetide treatment in an adult with Rett syndrome: A case report","name":"articletitle","label":"Article Title"},{"value":"Seizure: European Journal of Epilepsy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2026.08.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd on behalf of British Epilepsy Association.","name":"copyright","label":"Copyright"}]}}